R. Morera

705 total citations
12 papers, 530 citations indexed

About

R. Morera is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, R. Morera has authored 12 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 7 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in R. Morera's work include Inflammatory Bowel Disease (8 papers), Microscopic Colitis (5 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). R. Morera is often cited by papers focused on Inflammatory Bowel Disease (8 papers), Microscopic Colitis (5 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). R. Morera collaborates with scholars based in Italy, Spain and United States. R. Morera's co-authors include Gino Roberto Corazza, Antonio Di Sabatino, Rachele Ciccocioppo, P. Cazzola, Laura Ricevuti, S Tinozzi, Francesco Paolo Tinozzi, Stefano Gotti, Enrico Solcia and Ombretta Luinetti and has published in prestigious journals such as The American Journal of Gastroenterology, Alimentary Pharmacology & Therapeutics and Radiotherapy and Oncology.

In The Last Decade

R. Morera

12 papers receiving 518 citations

Peers

R. Morera

MB

GENET

SURGE

IMMUN

EPIDE

Peter Suenaert Belgium

Veerle Bulteel Belgium

Bernadien H. Jansen Netherlands

Italia Loddo Italy

Aimon K. Alkanani United States

Iulia Oancea Australia

Rafael Alós Spain

Luca Di Martino United States

Andrea Stroud United States

P. Cazzola Italy

Peter Suenaert Belgium

R. Morera

230 ×1.2

MB

205 ×1.1

GENET

157 ×1.1

SURGE

146 ×1.2

IMMUN

110 ×1.1

EPIDE

Citations per year, relative to R. Morera R. Morera (= 1×) peers Peter Suenaert

Countries citing papers authored by R. Morera

Since Specialization

Citations

This map shows the geographic impact of R. Morera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Morera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Morera more than expected).

Fields of papers citing papers by R. Morera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Morera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Morera. The network helps show where R. Morera may publish in the future.

Co-authorship network of co-authors of R. Morera

This figure shows the co-authorship network connecting the top 25 collaborators of R. Morera. A scholar is included among the top collaborators of R. Morera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Morera. R. Morera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Marruecos, J., Jordi Rubió‐Casadevall, Antonio López–Pousa, et al.. (2019). PD-029 Phase II trial: melatonin oral gel for prevention of mucositis in oropharynx and oral cavity tumors. Radiotherapy and Oncology. 132. 16–17. 1 indexed citations

2.

Sabatino, Antonio Di, P. Cazzola, Rachele Ciccocioppo, et al.. (2007). Efficacy of butyrate in the treatment of mild to moderate Crohn's disease. 1(1). 31–35. 12 indexed citations

3.

Sabatino, Antonio Di, Maria Manuela Rosado, P. Cazzola, et al.. (2006). Splenic hypofunction and the spectrum of autoimmune and malignant complications in celiac disease. Digestive and Liver Disease. 38. S18–S19. 12 indexed citations

4.

Sabatino, Antonio Di, R. Morera, P. Cazzola, et al.. (2006). Transforming Growth Factor-β Signaling and Matrix Metalloproteinase Pattern in Intestinal Strictures in Crohn's Disease. Inflammatory Bowel Diseases. 12. S22–S22. 3 indexed citations

5.

Sabatino, Antonio Di, R. Morera, Rachele Ciccocioppo, et al.. (2005). Oral butyrate for mildly to moderately active Crohn's disease. Alimentary Pharmacology & Therapeutics. 22(9). 789–794. 183 indexed citations

6.

Sabatino, Antonio Di, Maria Manuela Rosado, Rachele Ciccocioppo, et al.. (2005). Depletion of Immunoglobulin M Memory B Cells is Associated with Splenic Hypofunction in Inflammatory Bowel Disease. The American Journal of Gastroenterology. 100(8). 1788–1795. 77 indexed citations

7.

Sabatino, Antonio Di, Rita Carsetti, Maria Manuela Rosado, et al.. (2005). Immunoglobulin M memory B cell decrease in inflammatory bowel disease.. PubMed. 8(5). 199–203. 15 indexed citations

8.

Sabatino, Antonio Di, Rachele Ciccocioppo, Elia Armellini, et al.. (2004). Serum bFGF and VEGF Correlate Respectively with Bowel Wall Thickness and Intramural Blood Flow in Crohn’s Disease. Inflammatory Bowel Diseases. 10(5). 573–577. 80 indexed citations

9.

Sabatino, Antonio Di, Rachele Ciccocioppo, Ombretta Luinetti, et al.. (2003). Increased Enterocyte Apoptosis in Inflamed Areas of Crohn's Disease. Diseases of the Colon & Rectum. 46(11). 1498–1507. 127 indexed citations

10.

Sabatino, Antonio Di, Rachele Ciccocioppo, L. Benazzato, et al.. (2002). 44 P Serum basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) in Crohn's disease patients treated with infliximab. Digestive and Liver Disease. 34. A87–A87. 1 indexed citations

11.

Jl, Alvarez-Sala, et al.. (1996). Requisitos para la acreditación de unidades docentes en la especialidad de neumología. Archivos de Bronconeumología. 32(3). 142–144. 3 indexed citations

12.

Calero, Sofı́a, et al.. (1992). [Quality of life in arterial hypertension].. PubMed. 98(13). 486–90. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact